Cardiac side effects of molecular targeted therapies: Towards a better dialogue between oncologists and cardiologists
Authors:
- Stephane EderhySEStephane Ederhy
- Hassan IzzedineHIHassan Izzedine
- Christophe MassardCMChristophe Massard
- Ghislaine DufaitreGDGhislaine Dufaitre
- Jean Philippe SpanoJSJean Philippe Spano
- Gerard MilanoGMGerard Milano
- Catherine MeulemanCMCatherine Meuleman
- Benjamin BesseBBBenjamin Besse
- Franck BoccaraFBFranck Boccara
- David KahyatDKDavid Kahyat
- Ariel CohenACAriel Cohen
- Jean Charles SoriaJSJean Charles Soria
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 80 (3) , 369-379
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoringBritish Journal of Cancer, 2009
- An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxicJournal of Clinical Investigation, 2007
- Cardiotoxicity associated with tyrosine kinase inhibitor sunitinibThe Lancet, 2007
- Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trialsBMC Cancer, 2007
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C β-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced CancerClinical Cancer Research, 2007
- Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005European Journal of Cancer, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Cardiac Studies in Patients Treated with Depsipeptide, FK228, in a Phase II Trial for T-Cell LymphomaClinical Cancer Research, 2006
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Angiogenic growth factors and hypertensionAngiogenesis, 2004